Standard
Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial. / Finer, N; Hakim, M. Al; Astrup, Arne; Harper, A; Lean, M; Niskanen, L; Rasmussen, M.F.; Rissanen, A.; Rössner, S; Van Gaal, L.
In:
Diabetologia, Vol. 52, No. Suppl. 1, 2009, p. S11-S12.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Finer, N, Hakim, MA, Astrup, A, Harper, A, Lean, M, Niskanen, L, Rasmussen, MF, Rissanen, A, Rössner, S & Van Gaal, L 2009, 'Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial.', Diabetologia, vol. 52, no. Suppl. 1, pp. S11-S12.
APA
Finer, N., Hakim, M. A., Astrup, A., Harper, A., Lean, M., Niskanen, L., Rasmussen, M. F., Rissanen, A., Rössner, S., & Van Gaal, L. (2009). Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial. Diabetologia, 52(Suppl. 1), S11-S12.
Vancouver
Finer N, Hakim MA, Astrup A, Harper A, Lean M, Niskanen L et al. Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial. Diabetologia. 2009;52(Suppl. 1):S11-S12.
Author
Finer, N ; Hakim, M. Al ; Astrup, Arne ; Harper, A ; Lean, M ; Niskanen, L ; Rasmussen, M.F. ; Rissanen, A. ; Rössner, S ; Van Gaal, L. / Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial. In: Diabetologia. 2009 ; Vol. 52, No. Suppl. 1. pp. S11-S12.
Bibtex
@article{ce355260156711df803f000ea68e967b,
title = "Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial.",
author = "N Finer and Hakim, {M. Al} and Arne Astrup and A Harper and M Lean and L Niskanen and M.F. Rasmussen and A. Rissanen and S R{\"o}ssner and {Van Gaal}, L",
note = "Udgivelsesdato: september Volumne: 52; null ; Conference date: 29-09-2009 Through 02-10-2009",
year = "2009",
language = "English",
volume = "52",
pages = "S11--S12",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "Suppl. 1",
}
RIS
TY - ABST
T1 - Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial.
AU - Finer, N
AU - Hakim, M. Al
AU - Astrup, Arne
AU - Harper, A
AU - Lean, M
AU - Niskanen, L
AU - Rasmussen, M.F.
AU - Rissanen, A.
AU - Rössner, S
AU - Van Gaal, L
N1 - Conference code: 45
PY - 2009
Y1 - 2009
M3 - Conference abstract in journal
VL - 52
SP - S11-S12
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - Suppl. 1
Y2 - 29 September 2009 through 2 October 2009
ER -
